Ghost Tree Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Ghost Tree Capital’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-385,000	Closed	-$12.8M	–	59
2020 Q2	$12.8M	Sell	385,000 -15,000	-4%	-$478K	3.38%	10
2020 Q1	$10.9M	Hold	400,000	–	–	2.89%	12
2019 Q4	$7.89M	Buy	400,000 +50,000	+14%	+$800K	1.5%	24
2019 Q3	$4.54M	Sell	350,000 -150,000	-30%	-$1.81M	1.16%	25
2019 Q2	$6.22M	Hold	500,000	–	–	1.29%	24
2019 Q1	$7.26M	Buy	500,000 +175,000	+54%	+$2.24M	1.9%	21
2018 Q4	$3.59M	Buy	+325,000	New	+$4.52M	1.3%	27
2018 Q2	–	Sell	-500,000	Closed	-$9.07M	–	67
2018 Q1	$9.07M	Buy	+500,000	New	+$8.34M	1.84%	17

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Ghost Tree Capital's MNTA Position: Q3 2020 in Review

Ghost Tree Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 385,000 shares — an estimated $12.8M sold.

Ghost Tree Capital first reported a position in MNTA in Q1 2018 and held it in 8 quarters. The position peaked at $12.8M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Ghost Tree Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Ghost Tree Capital sold 385,000 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $12.8M.
Ghost Tree Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 8 quarters.
Ghost Tree Capital's Momenta Pharmaceuticals, Inc. position peaked at $12.8M in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Ghost Tree Capital's 13F filing for Q3 2020, filed 16 Nov 2020.